Diamines Q1 FY27: consolidated loss narrows to ₹0.1 Cr YoY as standalone swings to profit

Diamines & Chemicals reported consolidated revenue of ₹14.37 Cr for Q1 FY27 (quarter ended June 30, 2026), up 17.3% YoY from ₹12.25 Cr and up 54.8% QoQ from ₹9.29 Cr (the March quarter is seasonally softer for this specialty-chemicals business). The consolidated net loss narrowed sharply to ₹0.10 Cr from a ₹2.81 Cr loss a year ago (-96.3% YoY) and a ₹2.42 Cr loss last quarter (-95.7% QoQ); consolidated PBT was a marginal ₹-0.05 Cr versus ₹-2.96 Cr YoY, effectively a break-even quarter at the operating level. The consolidated and standalone numbers diverge in sign this quarter: standalone (parent-only) swung to a ₹0.27 Cr profit (EPS ₹0.27) from a ₹2.39 Cr loss YoY, while the consolidated entity stayed marginally loss-making. The gap between the two is entirely attributable to the wholly-owned subsidiary DACL Fine Chem, which posted a ₹0.34 Cr net loss this quarter, plus a further ₹0.056 Cr share-of-loss from associate KLJ Organics Diamines — both drags layered on an otherwise-profitable parent. At the standalone level, the swing to profit was driven mainly by Other Expenses falling to ₹3.83 Cr from ₹7.85 Cr YoY (-51.2%), even as Cost of Materials Consumed rose 21.4% to ₹7.83 Cr (slightly ahead of the 17.5% standalone revenue growth) — cost discipline on the other-expenses line more than offset a modest rise in material-cost intensity. No formal revenue or profit guidance is on record for this company — management's board disclosure for this result focuses on capex and corporate-structure items rather than quantitative outlook, so the quarter cannot be graded against a prior guide (vsGuidance: unknown). No analyst consensus or street preview could be identified either, consistent with the company's scale (~₹14 Cr quarterly consolidated revenue sits outside typical brokerage coverage). Two board actions tie directly to the numbers: the board approved an additional ₹40 Cr investment into DACL Fine Chem (via loan/debenture/equity) to fund the new chemical plant, which management says has reached substantial mechanical and commissioning completion but has not yet started commercial production pending optimization of the downstream distillation process — the likely source of the subsidiary's ongoing losses. Separately, the board discontinued the long-dormant Trading Division (Fruits & Vegetables segment), which had zero revenue since last year and had contributed a ₹3.58 Cr segment loss in FY26; its removal should simplify segment reporting going forward with no income-statement impact this quarter. Going into Q2 FY27, the key markers are whether the new plant reaches commercial production (removing the subsidiary drag that is currently the sole reason consolidated results trail standalone), and whether the consolidated entity — now within ₹0.10 Cr of break-even — crosses into profit.